Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Capecitabine (Primary)
- Indications Advanced breast cancer; Gastric cancer
- Focus Therapeutic Use
- 17 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 17 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
- 14 Mar 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.